[30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate

C52H58N4O10 — CID 162859200

IUPAC[30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate
SMILESCC=C(C(=O)OC1Cc2c3c(c4oc(CO)cc(=O)c4c2O)C2c4ccnc(N)c4C(CCc4ccc(O)cc4C2CO)CC(Cc2cnc4c(c2)CCC(C)N4)C1(C)O3)C1(O)CCCC1
InChIInChI=1S/C52H58N4O10/c1-4-38(52(63)14-5-6-15-52)50(62)65-40-22-36-45(61)43-39(60)21-33(24-57)64-47(43)44-42-34-13-16-54-48(53)41(34)29(10-9-28-11-12-32(59)20-35(28)37(42)25-58)19-31(51(40,3)66-46(36)44)18-27-17-30-8-7-26(2)56-49(30)55-23-27/h4,11-13,16-17,20-21,23,26,29,31,37,40,42,57-59,61,63H,5-10,14-15,18-19,22,24-25H2,1-3H3,(H2,53,54)(H,55,56)
InChIKeyQENZWNTVVFRSEF-UHFFFAOYSA-N
MW899.05 g/mol
LogP6.87
Rot. Bonds7

About [30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate

[30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate (PubChem CID 162859200) has the molecular formula C52H58N4O10 and a molecular weight of 899.05 g/mol. Its IUPAC name is [30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate.

Molecular Properties

Compound Name[30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate
PubChem CID162859200
Molecular FormulaC52H58N4O10
Molecular Weight899.05 g/mol
Exact Mass898.42
IUPAC Name[30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate
SMILESCC=C(C(=O)OC1Cc2c3c(c4oc(CO)cc(=O)c4c2O)C2c4ccnc(N)c4C(CCc4ccc(O)cc4C2CO)CC(Cc2cnc4c(c2)CCC(C)N4)C1(C)O3)C1(O)CCCC1
InChIInChI=1S/C52H58N4O10/c1-4-38(52(63)14-5-6-15-52)50(62)65-40-22-36-45(61)43-39(60)21-33(24-57)64-47(43)44-42-34-13-16-54-48(53)41(34)29(10-9-28-11-12-32(59)20-35(28)37(42)25-58)19-31(51(40,3)66-46(36)44)18-27-17-30-8-7-26(2)56-49(30)55-23-27/h4,11-13,16-17,20-21,23,26,29,31,37,40,42,57-59,61,63H,5-10,14-15,18-19,22,24-25H2,1-3H3,(H2,53,54)(H,55,56)
InChIKeyQENZWNTVVFRSEF-UHFFFAOYSA-N
XLogP6.87
TPSA230.72 Ų
H-Bond Donors7
H-Bond Acceptors14
Rotatable Bonds7
Heavy Atoms66
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500899.05
LogP ≤ 56.87
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze [30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate?
The IUPAC name of [30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate (CID 162859200) is [30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate.
What is the SMILES notation for [30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate?
The canonical SMILES for [30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate is CC=C(C(=O)OC1Cc2c3c(c4oc(CO)cc(=O)c4c2O)C2c4ccnc(N)c4C(CCc4ccc(O)cc4C2CO)CC(Cc2cnc4c(c2)CCC(C)N4)C1(C)O3)C1(O)CCCC1.
What is the InChIKey of [30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate?
The InChIKey is QENZWNTVVFRSEF-UHFFFAOYSA-N. The full InChI is InChI=1S/C52H58N4O10/c1-4-38(52(63)14-5-6-15-52)50(62)65-40-22-36-45(61)43-39(60)21-33(24-57)64-47(43)44-42-34-13-16-54-48(53)41(34)29(10-9-28-11-12-32(59)20-35(28)37(42)25-58)19-31(51(40,3)66-46(36)44)18-27-17-30-8-7-26(2)56-49(30)55-23-27/h4,11-13,16-17,20-21,23,26,29,31,37,40,42,57-59,61,63H,5-10,14-15,18-19,22,24-25H2,1-3H3,(H2,53,54)(H,55,56).
What are the key properties of [30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate?
[30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate has a molecular weight of 899.05 g/mol, XLogP of 6.87, 7 rotatable bonds, 7 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [30-amino-9,22-dihydroxy-5,25-bis(hydroxymethyl)-13-methyl-14-[(7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl]-7-oxo-4,12-dioxa-29-azaheptacyclo[14.9.6.210,13.02,11.03,8.019,24.026,31]tritriaconta-2(11),3(8),5,9,19(24),20,22,26(31),27,29-decaen-32-yl] 2-(1-hydroxycyclopentyl)but-2-enoate is sourced from PubChem (CID 162859200), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).